Selenoproteins of the thyroid gland: Expression, localization and possible function of glutathione peroxidase 3

Biological Chemistry

Volumn 388, Issue 10, 2007, Pages 1053-1059

  Schmutzler, Cornelia ^a   Mentrup, Birgit ^a,d   Schomburg, Lutz ^a   Hoang Vu, Cuong ^b   Herzog, Volker ^c   Köhrle, Josef ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Deiodinase; Glutathione peroxidase 1; Glutathione peroxidase 3; Glutathione peroxidase 4; Selenoprotein 15; Selenoprotein P; Thyroglobulin

Indexed keywords

DODECYL SULFATE SODIUM; ENZYME; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 3; GLUTATHIONE PEROXIDASE 4; HYDROGEN PEROXIDE; MESSENGER RNA; PROTEIN; SELENOPROTEIN; SELENOPROTEIN 15; SELENOPROTEIN P; THYROGLOBULIN; UNCLASSIFIED DRUG;

ARTICLE; CELL TYPE; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; ENZYME LOCALIZATION; EXTRACTION; GERM CELL; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LEUKOCYTE; NORTHERN BLOTTING; POLYMERIZATION; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THYROID CANCER; THYROID CELL; THYROID FOLLICLE CELL; THYROID GLAND;

BLOTTING, NORTHERN; CELL LINE, TUMOR; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; RNA, MESSENGER; SELENOPROTEINS; THYROID GLAND;

EID: 35348852007     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.122     Document Type: Article

References (38)

1. Barden, C.B., Shister, K.W., Zhu, B., Guiter, G., Greenblatt, D.Y., Zeiger, M.A., and Fahey, T.J. III (2003). Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin. Cancer Res. 9, 1792-1800.
2. Behne, D., Hilmert, H., Scheid, S., Gessner, H., and Elger, W. (1988). Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim. Biophys. Acta 966, 12-21.
3. Bermano, G., Nicol, F., Dyer, J.A., Sunde, R.A., Beckett, G.J., Arthur, J.R., and Hesketh, J.E. (1995). Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem. J. 311, 425-430.
4. Berndorfer, U., Wilms, H., and Herzog, V. (1996). Multimerization of thyroglobulin (TG) during extracellular storage: isolation of highly cross-linked Tg from human thyroids. J. Clin. Endocrinol. Metab. 81, 1918-1926.
5. Brown, L.M., Helmke, S.M., Hunsucker, S.W., Netea-Maier, R.T., Chiang, S.A., Heinz, D.E., Shroyer, K.R., Duncan, M.W., and Haugen, B.R. (2006). Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol. Carcinog. 45, 613-626.
6. Chang, P.W., Tsui, S.K., Liew, C., Lee, C.C., Waye, M.M., and Fung, K.P. (1997). Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. J. Cell. Biochem. 64, 217-224.
7. Chevillard, S., Ugolin, N., Vielh, P., Ory, K., Levalois, C., Elliott, D., Clayman, G.L., and El-Naggar, A.K. (2004). Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin. Cancer. Res. 10, 6586-6597.
8. Colzani, R.M., Alex, S., Fang, S.L., Stone, S., and Braverman, L.E. (1999). Effects of iodine repletion on thyroid morphology in iodine and/or selenium deficient rat term fetuses, pups and mothers. Biochimie 81, 485-491.
9. Dickson, R.C. and Tomlinson, R.H. (1967). Selenium in blood and human tissues. Clin. Chim. Acta 16, 311-321.
10. Duntas, L.H., Mantzou, E., and Koutras, D.A. (2003). Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur. J. Endocrinol. 148, 389-393.
11. Ekholm, R. and Björkman, U. (1997). Glutathione peroxidase degrades intracellular hydrogen peroxide and thereby inhibits intracellular protein iodination in thyroid epithelium. Endocrinology 138, 2871-2878.
12. Gärtner, R. and Gasnier, B.C. (2003). Selenium in the treatment of autoimmune thyroiditis. Biofactors 19, 165-170.
13. Gärtner, R., Gasnier, B.C., Dietrich, J.W., Krebs, B., and Angstwurm, M.W. (2002). Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab. 87, 1687-1691.
14. Glattre, E., Thomassen, Y., Thoresen, S.O., Haldorsen, T., Lund-Larsen P.G., Theodorsen, L., and Aaseth, J. (1989). Prediagnostic serum selenium in a case-control study of thyroid cancer. Int. J. Epidemiol. 18, 45-49.
15. Hasegawa, Y., Takano, T., Miyauchi, A., Matsuzuka, F., Yoshida, H., Kuma, K., and Amino, N. (2002). Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma. Cancer Lett. 182, 69-74.
16. Hill, K.E., Zhou, J., McMahan, W.J., Motley, A.K., Atkins, J.F., Gesteland, R.F., and Burk, R.F. (2003). Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem. 278, 13640-13646.
17. Howie, A.F., Walker, S.W., Akesson, B., Arthur, J.R., and Beckett, G.J. (1995). Thyroidal extracellular glutathione peroxidase: a potential regulator of thyroid-hormone synthesis. Biochem. J. 308, 713-717.
18. Kim, H., Kang, H.J., You, K.T., Kim, S.H., Lee, K.Y., Kim, T.I., Kim, C., Song, S.Y., Kim, H.J., Lee, C., and Kim, H. (2006). Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6, 3466-3476.
19. Klein, M., Gestmann, I., Berndorfer, U., Schmitz, A., and Herzog V. (2000). The thioredoxin boxes of thyroglobulin: possible implications for intermolecular disulfide bond formation in the follicle lumen. Biol. Chem. 381, 593-601.
20. Köhrle, J. (1997). Thyroid carcinoma: interrelationships between local thyroid hormone metabolism by the type I 5′-deiodinase and the expression of thyroid hormone receptors and other thyroid-specific (de-)differentiation markers. Curr. Top. Pathol. 91, 83-116.
21. Köhrle, J. (2005). Selenium and the control of thyroid hormone metabolism. Thyroid 15, 841-853.
22. Köhrle, J., Jakob, F., Contempré, B., and Dumont, J.E. (2005). Selenium, the thyroid, and the endocrine system. Endocr. Rev. 26, 944-984.
23. Kroll, T.G., Sarraf, P., Pecciarini, L., Chen, C.J., Mueller, E., Spiegelman, B.M., and Fletcher, J.A. (2000). PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma wcorrectedx. Science 289, 1357-1360.
24. Kucharzewski, M., Braziewicz, J., Majewska, U., and Gozdz, S. (2003). Copper, zinc, and selenium in whole blood and thyroid tissue of people with various thyroid diseases. Biol. Trace Elem. Res. 93, 9-18.
25. Kuiper, G.G.J.M., Wassen, F., Klootwijk, W., van Toor, H., Kaptein, E., and Visser, T.J. (2003). Molecular basis for the substrate specificity of cat type I iodothyronine deiodinase. Endocrinology 144, 5411-5421.
26. Lincoln, D.T., Ali Emadi, E.M., Tonissen, K.F., and Clarke, F.M. (2003). The thioredoxin-thioredoxin reductase system: overexpression in human cancer. Anticancer Res. 23, 2425-2433.
27. Menth, M., Schmutzler, C., Mentrup, B., Hoang-Vu, C., Takahashi, K., Honjoh, T., and Köhrle, J. (2005). Selenoprotein expression in Hurthle cell carcinomas and in the human Hurthle cell carcinoma line XTC.UC1. Thyroid 15, 405-416.
28. Missero, C., Cobellis, G., De Felice, M., and di Lauro, R. (1998). Molecular events involved in the differentiation of thyroid follicular cells. Mol. Cell. Endocrinol. 140, 37-43.
29. Pasieka, J.L. (2003). Anaplastic thyroid cancer. Curr. Opin. Oncol. 15, 78-83.
30. Ris-Stalpers, C., Moreno, J.C., De Vijlder, J.J.M., and Pauws, E. (2001). How serial analysis of gene expression (SAGE) can be applied to identify novel genes involved in thyroid cell biology. J. Endocrinol. Invest. 24, p 3 (Abstract).
31. Ros, P., Rossi, D.L., Acebron, A., and Santisteban, P. (1999). Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Biochimie 81, 389-396.
32. Schomburg, L., Schweizer, U., Holtmann, B., Flohe, L., Sendtner, M., and Köhrle, J. (2003). Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 370, 397-402.
33. Takano, T., Hasegawa, Y., Matsuzuka, F., Miyauchi, A., Yoshida, H., Higashiyama, T., Kuma, K., and Amino, N. (2000). Gene expression profiles in thyroid carcinomas. Br. J. Cancer 83, 1495-1502.
34. Taurog, A. (2005). Hormone synthesis. In: Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 9th edition, L.E. Braverman and R.D. Utiger, eds. (Philadelphia, USA: Lippincott, Williams and Wilkins).
35. Turker, O., Kumanlioglu, K., Karapolat, I., and Dogan, I. (2006). Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol. 190, 151-156.
36. Ursini, F., Heim, S., Kiess, M., Maiorino, M., Roveri, A., Wissing, J., and Flohe, L. (1999). Dual function of the selenoprotein PHGPx during sperm maturation. Science 285, 1393-1396.
37. Vanderpump, M.P., Tunbridge, W.M., French, J.M., Appleton, D., Bates, D., Clark, F., Grimley Evans, J., Hasan, D.M., Rodgers, H., Tunbridge, F., et al. (1995). The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf.) 43, 55-68.
38. Yoshimura, S., Watanabe, K., Suemizu, H., Onozawa, T., Mizoguchi, J., Tsuda, K., Katta, H., and Moriuchi, T. (1991). Tissue specific expression of the plasma glutathione peroxidase gene in rat kidney. J. Biochem. 109, 918-923.